# Reasons for hesitancy and acceptance of COVID-19 vaccination among the Congolese population: a scoping review

**Authors:** Genèse Lobukulu Lolimo, Rodrigue Khonde, Hervé Matondo, Junias Kabele, Yannick Musawu K, Senait Alemayehu Beshah, Daniel Malik Achala, Grace Njeri Muriithi, Elizabeth Naa Adukwei Adote, Elias Asfaw Zegeye, Chinyere Ojiugo Mbachu, John Ele-Ojo Ataguba, Fadima Inna Kamina Yaya Bocoum, Serge Mayaka Manitu

PMC · DOI: 10.3389/frhs.2025.1647147 · Frontiers in Health Services · 2026-02-17

## TL;DR

This study explores why many people in the Democratic Republic of Congo are hesitant to get vaccinated against COVID-19, despite initial willingness.

## Contribution

The study identifies specific factors influencing vaccine hesitancy and acceptance in the Congolese population through a scoping review.

## Key findings

- Safety concerns and mistrust in vaccine effectiveness are major barriers to vaccination in the DRC.
- Facilitators of vaccine acceptance include prior family vaccination and perceived risk of infection.
- Healthcare professionals and males are more likely to accept the vaccine.

## Abstract

Despite over 9.6 billion COVID-19 vaccine doses administered globally, vaccination access remains highly unequal. North America and Western Europe have over 50% vaccination coverage, contrasting sharply with African nations, like the Democratic Republic of Congo (DRC), which has under 10%. This scoping review explores the key factors contributing to the low COVID-19 vaccination rate in the Congolese population.

We conducted a scoping review using the Arksey and O'Malley framework, searching PubMed, ProQuest, and Scopus databases for peer-reviewed manuscripts published between 2019 and 2023. Six studies met the inclusion criteria, and focused on the factors of COVID-19 vaccine acceptance, hesitancy, and access in the DRC.

Although surveys indicated a high willingness on the part of the people to get vaccinated, only 2.7% of the population were fully vaccinated. The primary barrier to vaccination was safety concerns, specifically, perceptions of the vaccine as new and experimental (84.4%) and fear of side effects (83.3%). Additional hesitancy factors included mistrust in vaccine effectiveness (60.4%) and a general lack of confidence (60.0%). Facilitators of acceptance included prior family vaccination, perceived risk of infection, belief in the existence of the virus, and awareness of vaccination strategies. Sociodemographic factors such as being a healthcare professional or male also positively influenced uptake.

These findings highlight the gap between vaccine willingness and actual coverage in the DRC. Addressing safety concerns and building trust through targeted outreach, especially among key professional groups, may improve vaccine acceptance and equity.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** infection (MESH:D007239), COVID-19 (MESH:D000086382), malaria (MESH:D008288), Ebola (MESH:D019142), yellow fever (MESH:D015004), measles (MESH:D008457)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12953073/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12953073/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12953073/full.md

---
Source: https://tomesphere.com/paper/PMC12953073